Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MK-677 Results Timeline: Phase Comparison

Neurological Response 24–72 hours Ghrelin receptor activation in hypothalamus Increased appetite, improved sleep architecture (REM and slow-wave stages) 50% increase in REM sleep duration within 7 days Earliest and most consistent marker. If sleep quality does

This comparison does not assign a generated winner or score.

  • Neurological Response
  • 24–72 hours
  • Ghrelin receptor activation in hypothalamus
  • Increased appetite, improved sleep architecture (REM and slow-wave stages)
  • 50% increase in REM sleep duration within 7 days
  • Earliest and most consistent marker. If sleep quality doesn't improve within one week, dosing or purity may be insufficient
  • Recovery & Tissue Remodeling
  • 2–4 weeks
  • IGF-1-mediated collagen synthesis, mTOR pathway activation
  • Faster DOMS recovery, skin elasticity improvement, hair growth acceleration
  • 18–25% faster recovery of force production post-exercise
  • Subjective improvements are reliable at this phase. Objective measures (DEXA, imaging) are premature
  • Body Composition Shift
  • 8–16 weeks
  • Sustained elevation of GH/IGF-1 driving protein synthesis and lipolysis
  • Lean mass gain (1–2kg), visceral fat reduction (5–10%), improved muscle fullness
  • Mean 1.1kg fat-free mass increase at 8 weeks with resistance training
  • This is the outcome window most users target. Patience and consistency separate responders from non-responders
  • Metabolic Adaptation
  • 8–12 weeks
  • GH counter-regulatory effect on insulin, hepatic glucose output
  • Fasting glucose increase (5–15 mg/dL), possible transient insulin resistance
  • Fasting glucose elevation detectable by week 4–6
  • Monitor glucose closely if diabetic or pre-diabetic. Most healthy subjects tolerate this without progression
  • Bone & Connective Tissue
  • 12–24 months
  • Osteoblast stimulation, chondrocyte proliferation, tendon remodeling
  • Increased BMD (2–5%), cartilage thickness improvement, joint structural integrity
  • Significant BMD changes not detectable until month 9+
  • Longest timeline of any outcome. This is not a short-term intervention
More references

Related material